Regression of small resistance artery structural alterations in hypertension by appropriate antihypertensive treatment

Current Hypertension Reports

Volumn 12, Issue 2, 2010, Pages 80-85

  Agabiti Rosei, Enrico ^a   Rizzoni, Damiano ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Antihypertensive therapy; Hypertrophy; Microvasculature; Remodeling; Small artery

Indexed keywords

AMLODIPINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM ANTAGONIST; CANDESARTAN; CARVEDILOL; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; EPLERENONE; HYDROCHLOROTHIAZIDE; IRBESARTAN; ISRADIPINE; LISINOPRIL; LOSARTAN; NEBIVOLOL; NIFEDIPINE; OLMESARTAN; PERINDOPRIL; RAMIPRIL; TELMISARTAN; VALSARTAN;

ANTIHYPERTENSIVE THERAPY; ARTERIAL WALL THICKNESS; ARTERIOLE; ARTERY DIAMETER; ARTERY MEDIA; ARTERY RESISTANCE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CORONARY ARTERY DISEASE; DRUG EFFECT; ENZYME ACTIVITY; ENZYME REGULATION; ESSENTIAL HYPERTENSION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MICROCIRCULATION; MICROVASCULATURE; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PROGNOSIS; PULSE PRESSURE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; TREATMENT RESPONSE; TUNICA MEDIA;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; ARTERIES; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MICROVESSELS; PROGNOSIS; RISK FACTORS; TREATMENT OUTCOME; TUNICA MEDIA; VENTRICULAR REMODELING;

EID: 77953539721     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-010-0093-7     Document Type: Review

References (29)

1. Mulvany MJ, Aalkjaer C: Structure and function of small arteries. Physiol Rev 1990, 70:921-971.
2. Schiffrin EL: Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. Am J Hypertens 2004, 17(12 Pt 1):1192-1200.
3. Izzard AS, Rizzoni D., Agabiti-Rosei E, Heagerty AM: Small artery structure and hypertension: adaptive changes and target organ damage. J Hypertens 2005, 23:247-250.
4. Aalkjaer C, Haegerty AM, Petersen K.K., et al.: Evidence for increased media thickness, increased neural amine uptake, and depressed excitation-contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res 1987, 61(2):181-186.
5. Aalkjaer C, Eiskjaer H., Mulvany M.J., et al.: Abnormal structure and function of isolated subcutaneous resistance vessels from essential hypertensive patients despite antihypertensive treatment. J Hypertens 1989, 7:305-310.
6. Heagerty AM, Aalkjaaer C., Bund S.J., et al.: Small artery structure in hypertension. Dual process of remodeling and growth. Hypertension 1993; 21:391-397.
7. Rizzoni D, Porteri E., Castellano M., et al.: Vascular hypertrophy and remodeling in secondary hypertension. Hypertension 1996, 28:785-790.
8. Rizzoni D, Porteri E., Guelfi D., et al.: Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with non insulin dependent diabetes mellitus. Circulation 2001, 103:1238-1244.
9. Rizzoni D, Porteri E., Guelfi D., et al.: Cellular hypertrophy in subcutaneous small arteries of patients with renovascular hypertension. Hypertension 2000, 35:931-935.
10. Rizzoni D, Palombo C., Porteri E., et al.: Relationships between coronary vasodilator capacity and small artery remodeling in hypertensive patients. J Hypertens 2003, 21:625-632.
11. Rizzoni D, Porteri E., Boari GEM, et al.: Prognostic significance of small artery structure in hypertension. Circulation 2003, 108:2230-2235.
12. De Ciuceis C., Porteri E., Rizzoni D., et al.: Structural alterations of subcutaneous small arteries may predict major cardiovascular events in hypertensive patients. Am J Hypertens 2007; 20:846-852.
13. Mathiassen ON, Buus NH, Sihm I., et al: Small artery structure is an independent predictor of cardiovascular events in essential hypertension. J Hypertens 2007, 25:1021-1026.
14. Rizzoni D, Porteri E., Platto C., et al.: Morning rise of blood pressure and subcutaneous small resistance artery structure. J Hypertens 2007, 25:1698-1703.
15. Heagerty AM: Predicting hypertension complications from small artery structure. J Hypertens 2007, 25:939-940.
16. Mulvany MJ: Small artery structure: time to take note? [Editorial Commentary]. Am J Hypertens 2007, 20:853-854.
17. Agabiti Rosei E., Rizzoni D: The effects of hypertension on the structure of human resistance arteries. In Comprehensive Hypertension. Edited by Lip GYH and Hall JE. Philadelphia: Mosby Elsevier; 2007:579-590.
18. Agabiti-Rosei E., Heagerty AM, Rizzoni D: Effects of antihypertensive treatment on small artery remodelling. J Hypertens 2009, 27(6):1107-1114.
19. Mathiassen ON, Buus NH, Larsen M.L., et al.: Small artery structure adapts to vasodilatation rather than to blood pressure during antihypertensive treatment. J Hypertens 2007, 25:1027-1034.
20. Savoia C, Touyz RM, Endemann D.H., et al.: Angiotensin receptor blocker added to previous antihypertensive agents on arteries of diabetic hypertensive patients. Hypertension 2006, 48:271-277.
21. Rizzoni D, Porteri E., De Ciuceis C, et al.: Effects of treatment with candesartan or enalapril on subcutaneous small resistance artery structure in hypertensive patients with NIDDM. Hypertension 2005, 45(Part 2):659-665.
22. Park JB, Intengan HD, Schiffrin EL: Reduction of resistance artery stiffness by treatment with the AT(1) receptor antagonist losartan in essential hypertension. J Renin Angiotensin Aldosterone Syst 2000, 1(1):40-45.
23. Savoia C, Touyz RM, Amiri F., Schiffrin EL: Selective mineralocorticoid receptor blocker eplerenone reduces resistance artery stiffness in hypertensive patients. Hypertension 2008, 51:432-439.
24. Smith RD, Yokoyama H., Averill D.B., et al.: Reversal of vascular hypertrophy in hypertensive patients through blockade of angiotensin II receptors. J Am Soc Hypertens 2008, 2(3):165-172.
25. Rizzoni D, Muiesan ML, Porteri E., et al: Effect of long-term antihypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy. J Hypertens 1997, 15:197-204.
26. Endemann DH, Pu Q., De Ciuceis C, et al.: Persistent remodeling of resistance arteries in type 2 diabetic patients on antihypertensive treatment. Hypertension 2004, 43:399-404.
27. Porteri E, Rizzoni D., Muiesan M.L., et al.: Effect of treatment with telmisartan, ramipril or their combination on subcutaneous small resistance artery structure. Poster 1422, presented at the 19th European Meeting on Hypertension. Milan, Italy; June 12-16, 2009.
28. Mancia G, De Backer G, Dominiczak A, et al.: 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007, 25:1105-1187. (Pubitemid 46924065)
29. Harazny JM, Ritt M., Baleanu D., et al.: Increased wall:lumen ratio of retinal arterioles in male patients with a history of a cerebrovascular event. Hypertension 2007, 50:623-629.